Elon Musk's Neuralink Faces Setback in Human Trial

Neuralink, a company founded by Elon Musk, recently encountered a challenge during its initial human trial. The brain implant used in the trial experienced a complication where the thin wires within the brain moved out of place, reducing the effectiveness of recording brain signals. This issue had been known to the company for a few years, according to sources familiar with the situation.

The tiny wires, thinner than a human hair, that were part of the brain implant in the first patient retracted, causing a decrease in the number of electrodes capable of functioning properly. Neuralink has acknowledged this setback, emphasizing the difficulties faced during the trial phase.

Despite the setback faced by Neuralink in its human trial, the company continues to work towards developing innovative technologies to enhance our understanding of the brain. This experience serves as a reminder of the challenges involved in cutting-edge scientific research and the importance of perseverance in overcoming obstacles.